Eargo

About

Eargo is intended for people who have mild to moderate hearing loss.

San Jose,California,United States
101 - 250
https://www.eargo.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $29.30M
Industries: Audio,Health Care,Medical Device,Wearables
Founded date: Jan 1, 2010
Number Of Employee: 101 - 250
Operating Status: Active
Stock Symbol: nasdaq:EAR
Legal Name: Eargo Hearing, Inc.

Eargo is intended for people who have mild to moderate hearing loss..The company also offers online hearing screenings and virtual support, so customers don’t need to have an in-person visit. It offers a rechargeable hearing aids that can be controlled with a smartphone. Its innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility, and cost.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

11

$512.77M

Eargo has raised a total of $512.77M in funding over 2 rounds. Their latest funding was raised on Nov 29, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 29, 2022	Post-IPO Equity	$29.30M	—	—	—	Detail
Jun 27, 2022	Post-IPO Debt	$125M	1	Patient Square Capital	—	Detail
Oct 15, 2020	IPO	$141.30M	—	—	—	Detail
Jul 29, 2020	Series E	$81.57M	5	Gilde Healthcare Longitude Capital	—	Detail
Mar 5, 2019	Series D	$52M	5	Future Fund	—	Detail

Investors

Number of Lead Investors

Number of Investors

7

19

Eargo is funded by 19 investors. Patient Square Capital and Gilde Healthcare are the most recent investors.

Investor Name	Lead Investor	Funding Round
Patient Square Capital	Yes	Post-IPO Debt
Gilde Healthcare	Yes	Series E
Longitude Capital	Yes	Series E
Future Fund	Yes	Series D
Charles and Helen Schwab Foundation	—	Series E
Nan Fung Life Sciences	—	Series E
New Enterprise Associates	—	Series E
Maveron	—	Series D
Schwab Institutional	—	Series D
Charles Schwab Corporation	—	Series C